https://larvol.hashnode.dev/combination-of-durvalumab-with-etoposide-and-platinum 2024-05-24T05:04:53.739Z daily 0.8 https://larvol.hashnode.dev/evaluation-of-salivary-rna-in-subjects-scheduled-for-surgery-for-a-gynecologic-pathology 2024-05-24T05:01:04.737Z daily 0.8 https://larvol.hashnode.dev/pyrotinib-versus-thp-in-the-first-line-treatment-for-her2 2024-05-24T04:58:10.677Z daily 0.8 https://larvol.hashnode.dev/the-combination-of-adebrelimab-and-tp-regimen-for-neoadjuvant-therapy-in-patients 2024-05-24T04:54:17.380Z daily 0.8 https://larvol.hashnode.dev/vemurafenib-plus-cobimetinib-in-advanced 2024-05-24T04:51:32.762Z daily 0.8 https://larvol.hashnode.dev/the-combination-of-adebrelimab-and-tp-regimen-for-neoadjuvant-therapy 2024-05-23T11:13:21.938Z daily 0.8 https://larvol.hashnode.dev/primary-and-secondary-outcome-measures-in-a-study-of-prostate-specific-antigen-psa-doubling-time-and-disease-progression 2024-05-23T11:09:03.918Z daily 0.8 https://larvol.hashnode.dev/pain-levels-and-oral-mucositis-lesion-size-assessment-in-a-clinical-study 2024-05-23T11:03:18.853Z daily 0.8 https://larvol.hashnode.dev/combining-sbrt-with-chemoimmunotherapy-for-locally-advanced-oral-cavity-and-oropharyngeal-cancer 2024-05-23T10:56:40.322Z daily 0.8 https://larvol.hashnode.dev/clinical-trials-for-2019-000210-11 2024-05-16T12:04:12.143Z daily 0.8 https://larvol.hashnode.dev/relapse-prophylaxis-with-n-803-for-aml-and-mds-pts-following-allo-hsct 2024-05-16T11:58:46.982Z daily 0.8 https://larvol.hashnode.dev/il-2-select-tissue-collection-protocol-in-patients-with-advanced-melanoma 2024-05-16T11:56:18.197Z daily 0.8 https://larvol.hashnode.dev/utidelone-treated-for-the-recurrent-or-metastatic-urothelial-carcinoma 2024-05-16T11:54:20.523Z daily 0.8 https://larvol.hashnode.dev/arrx-in-combination-with-enzalutamide-in-metastatic-castration-resistant-prostate-cancer 2024-05-16T11:50:04.956Z daily 0.8 https://larvol.hashnode.dev/comparative-study-of-xrp9881-plus-cisplatin-versus-gemcitabine-plus-cisplatin-in-locally-advancedmetastatic-urothelial-tract-or-bladder-cancer 2024-05-16T11:11:05.828Z daily 0.8 https://larvol.hashnode.dev/bioequivalence-study-of-liposomal-cytarabinedaunorubicin-injection-in-elderly-aml-patients 2024-05-16T10:59:53.265Z daily 0.8 https://larvol.hashnode.dev/determining-safety-and-tolerability-of-interferon-beta-ifn-b-in-combination-with-zidovudine-azt-for-early-aids-related-kaposis-sarcoma 2024-05-16T10:53:28.624Z daily 0.8 https://larvol.hashnode.dev/determining-optimal-dose-and-safety-of-lde225-in-combination-with-everolimus-for-esophageal-or-gastroesophageal-junction-cancer 2024-05-16T10:49:24.326Z daily 0.8 https://larvol.hashnode.dev/comparative-study-of-bupropion-hydrochloride-versus-patients-choice-for-smoking-cessation-in-squamous-cell-head-and-neck-cancer-patients 2024-05-16T10:43:47.139Z daily 0.8 https://larvol.hashnode.dev/inclusion-and-exclusion-criteria-for-a-clinical-trial-evaluating-cldn182-targeted-therapy 2024-05-10T04:49:05.331Z daily 0.8 https://larvol.hashnode.dev/prado-study-neoadjuvant-immunotherapy-and-response-driven-therapy-in-stage-iii-melanoma 2024-05-10T04:44:16.747Z daily 0.8 https://larvol.hashnode.dev/investigation-of-combined-interferon-beta-and-zidovudine-therapy-for-early-aids-related-kaposis-sarcoma 2024-05-10T04:41:09.225Z daily 0.8 https://larvol.hashnode.dev/clinical-trial-outcomes-for-lde225-and-everolimus-combination-therapy-in-advanced-adenocarcinoma 2024-05-10T04:39:01.203Z daily 0.8 https://larvol.hashnode.dev/inclusion-criteria-for-a-randomized-trial-of-second-line-therapy-in-hormone-refractory-prostate-cancer 2024-05-10T04:22:09.023Z daily 0.8 https://larvol.hashnode.dev/prospective-study-of-first-line-p-gemox-therapy-in-nasal-type-extranodal-nkt-cell-lymphoma 2024-05-09T10:26:12.278Z daily 0.8 https://larvol.hashnode.dev/phase-iii-trial-comparing-selumetinib-to-standard-carboplatinvincristine-therapy-for-nf1-associated-low-grade-glioma 2024-05-09T10:25:11.200Z daily 0.8 https://larvol.hashnode.dev/phase-i-study-of-tremelimumab-in-japanese-patients-with-advanced-solid-malignancies 2024-05-09T10:23:46.631Z daily 0.8 https://larvol.hashnode.dev/phase-i-trial-of-gemcitabine-hydrochloride-and-alvocidib-in-solid-tumors-dose-finding-and-safety-evaluation 2024-05-09T10:22:49.780Z daily 0.8 https://larvol.hashnode.dev/phase-ii-trial-of-azacitidine-and-gemtuzumab-ozogamicin-in-older-patients-with-untreated-acute-myeloid-leukemia 2024-05-09T10:22:45.728Z daily 0.8 https://larvol.hashnode.dev/what-role-does-genetics-play-in-cancer-susceptibility-1-1-1-1-1-1-1 2024-05-02T08:00:17.497Z daily 0.8 https://larvol.hashnode.dev/what-role-does-genetics-play-in-cancer-susceptibility-1-1-1-1-1-1 2024-05-02T07:59:09.961Z daily 0.8 https://larvol.hashnode.dev/what-role-does-genetics-play-in-cancer-susceptibility-1-1-1-1-1 2024-05-02T07:58:19.716Z daily 0.8 https://larvol.hashnode.dev/what-role-does-genetics-play-in-cancer-susceptibility-1-1-1-1 2024-05-02T07:56:16.579Z daily 0.8 https://larvol.hashnode.dev/what-role-does-genetics-play-in-cancer-susceptibility-1-1-1 2024-04-30T07:51:53.210Z daily 0.8 https://larvol.hashnode.dev/what-role-does-genetics-play-in-cancer-susceptibility-1-1 2024-04-30T07:46:57.883Z daily 0.8 https://larvol.hashnode.dev/what-role-does-genetics-play-in-cancer-susceptibility-1 2024-04-30T07:40:54.773Z daily 0.8 https://larvol.hashnode.dev/what-role-does-genetics-play-in-cancer-susceptibility 2024-04-30T07:29:02.358Z daily 0.8 https://larvol.hashnode.dev/advancements-and-innovations-in-cancer-research-pioneering-pathways-to-healing-1-1-1-1-1-1-1-1-1-1 2024-04-24T10:11:31.187Z daily 0.8 https://larvol.hashnode.dev/advancements-and-innovations-in-cancer-research-pioneering-pathways-to-healing-1-1-1-1-1-1-1-1-1 2024-04-24T10:07:09.544Z daily 0.8 https://larvol.hashnode.dev/advancements-and-innovations-in-cancer-research-pioneering-pathways-to-healing-1-1-1-1-1-1-1-1 2024-04-24T10:03:58.544Z daily 0.8 https://larvol.hashnode.dev/advancements-and-innovations-in-cancer-research-pioneering-pathways-to-healing-1-1-1-1-1-1-1 2024-04-24T09:58:26.119Z daily 0.8 https://larvol.hashnode.dev/advancements-and-innovations-in-cancer-research-pioneering-pathways-to-healing-1-1-1-1-1-1 2024-04-24T09:56:18.552Z daily 0.8 https://larvol.hashnode.dev/advancements-and-innovations-in-cancer-research-pioneering-pathways-to-healing-1-1-1-1-1 2024-04-22T12:57:22.330Z daily 0.8 https://larvol.hashnode.dev/advancements-and-innovations-in-cancer-research-pioneering-pathways-to-healing-1-1-1-1 2024-04-22T12:14:21.842Z daily 0.8 https://larvol.hashnode.dev/advancements-and-innovations-in-cancer-research-pioneering-pathways-to-healing-1-1-1 2024-04-22T12:10:20.109Z daily 0.8 https://larvol.hashnode.dev/advancements-and-innovations-in-cancer-research-pioneering-pathways-to-healing-1-1 2024-04-22T12:08:24.023Z daily 0.8 https://larvol.hashnode.dev/advancements-and-innovations-in-cancer-research-pioneering-pathways-to-healing-1 2024-04-22T12:06:22.724Z daily 0.8 https://larvol.hashnode.dev/advancements-and-innovations-in-cancer-research-pioneering-pathways-to-healing 2024-04-22T12:03:14.437Z daily 0.8 https://larvol.hashnode.dev/can-vaccines-help-prevent-cancer-1-1-1-1-1-1-1-1 2024-04-19T11:19:45.416Z daily 0.8 https://larvol.hashnode.dev/can-vaccines-help-prevent-cancer-1-1-1-1-1-1-1 2024-04-19T11:02:08.621Z daily 0.8